Sol-Gel Technologies (SLGL) Cash & Equivalents Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - | -3.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.94% |
| Sep 30, 2025 | -7.61% |
| Jun 30, 2025 | 21.03% |
| Mar 31, 2025 | -7.37% |
| Dec 31, 2024 | -1.00% |
| Sep 30, 2024 | -32.35% |
| Jun 30, 2024 | 1.17% |
| Mar 31, 2024 | -3.94% |
| Dec 31, 2023 | 1.80% |
| Sep 30, 2023 | 33.01% |
| Jun 30, 2023 | 42.09% |
| Mar 31, 2023 | 45.73% |
| Dec 31, 2022 | 9.77% |
| Sep 30, 2022 | 3.62% |
| Jun 30, 2022 | -26.28% |
| Mar 31, 2022 | 37.50% |
| Dec 31, 2021 | 55.66% |
| Sep 30, 2021 | 48.39% |
| Jun 30, 2021 | -15.13% |
| Mar 31, 2021 | -45.88% |
| Dec 31, 2020 | 12.34% |
| Dec 31, 2019 | 10.37% |